Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

4.41
Delayed Data
As of Jun 15
 +0.47 / +11.93%
Today’s Change
2.70
Today|||52-Week Range
5.11
+27.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization36.0K96.0K206.0K64.0K
 
 
 
 
 
 
Operating ExpensesGross Income-36.0K-96.0K-206.0K-64.0K
 
 
 
 
 
General Expenses27.6M48.1M40.4M21.2M
 
 
 
 
 
Research And Development18.6M35.5M30.1M13.3M
 
 
 
 
 
Total Operating Expenses27.7M48.2M40.6M21.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.7M-48.2M-40.6M-21.3M
 
 
 
 
 
Extraordinary Credit0.000.0073.0K6.0K
 
 
 
Other Expenses0.000.0054.0K162.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-27.6M-48.1M-40.4M-21.1M
 
 
 
 
 
Income Taxes0.000.00-1.6M0.00
 
 
Net Income-27.6M-48.1M-38.8M-21.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS998.6K1.7M2.5M6.7M
 
 
 
 
 
Shares To Calculate EPS Diluted998.6K1.7M2.5M6.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$27.70-$28.60-$15.41-$3.17
 
 
 
 
 
EPS Diluted-$27.70-$28.60-$15.41-$3.17